REGISTERED NUMBER: 04851784 (England and Wales)

Financial Statements for the Year Ended 31 December 2024

for

Willan Pharm Limited

Page

Statement of Financial Position

1

CURRENT ASSETS

34,770

27,131

CREDITORS

Amounts falling due within one year

(33,442

)

(23,509

)

NET CURRENT ASSETS

1,328

3,622

TOTAL ASSETS LESS CURRENT LIABILITIES

1,328

3,622

CREDITORS

Amounts falling due after more than one year

(979

)

(3,004

)

NET ASSETS

349

618

CAPITAL AND RESERVES

349

618

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Willan Pharm Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

04851784

Registered office:

15 Albany Crescent

Edgware

Middlesex

HA8 5AL

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2023 - 1 ) .

3.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 December 2024 and 31 December 2023:

31.12.24

31.12.23

£

£

W Opoku-Asamoah

Balance outstanding at start of year

16,577

10,754

Amounts advanced

1,404

5,823

Amounts repaid

-

-

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

17,981

16,577

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 19 September 2025 and were signed by:

W Opoku-Asamoah - Director